Head and Neck Squamous Cell Carcinoma Market Size

Head and Neck Squamous Cell Carcinoma (HNSCC) Market size was valued at USD 2.37 billion in 2024 and is likely to exceed USD 7.08 billion by the end of 2037, expanding at over 8.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of head and neck squamous cell carcinoma is evaluated at USD 2.54 billion. The growth of the market can be attributed to the increasing cases of head and neck cancer throughout the world. For instance, head and neck cancer claimed the lives of nearly 280,605 people globally in 2020. Further, the worldwide surging demand for combination therapy for the effective treatment of head and neck cancer is also estimated to radically spur the market growth during the forecast period.

In addition to these, factors that are believed to fuel the market growth of head and neck squamous cell carcinoma (HNSCC) include the escalating use of tobacco among the people which is boosting cases of head and cancer throughout the world. Based on the World Health Organization report, in 2020, 36.7% of all men and 7.8% of all women consumed tobacco. This represents 22.3% of the world's population. Additionally, the growing advancement in the screening procedure of cancer and a very prominent presence of drugs comprising Avelumab, Ipilimumab, Atezolizumab, and so on are also predicted to present the potential for market expansion over the projected period. In addition to this, worldwide escalating demand for non-surgical therapeutics comprising targeted therapy, chemotherapy, and so on is also anticipated to spur market growth throughout the projected time frame.